STEAP2 and hepatocellular carcinoma: This hypothesis is supported by recent experimental data on the malignancy-promoting role of the Six Transmembrane Epithelial Antigen of Prostate 2 (STEAP2) in HCC cells, which indirectly contributes to the cellular entry of Cu [11].